Roche Diagnostics develops innovative products and services that address the prevention, diagnosis, monitoring, screening and treatment of diseases
At Roche Diagnostics we believe time is precious and we are dedicated to providing diagnostic tests and services that give people more time with their loved ones.
We are proud to be the UK’s leading provider of in vitro diagnostics tests1 and in 2020 more than 820 million Roche diagnostic tests were used by clinicians across the UK to confirm, rule out or manage health conditions including cancer, heart disease, diabetes, COVID-19, hepatitis, human papillomavirus (HPV) and many others2.
Pathway project evaluation between Innovation Agency, the Academic Health Science Network for the North West Coast (IA), Roche Products Limited and Roche Diagnostics Limited.
Heart failure affects nearly 1 million people in the UK, and there are an estimated 200,000 new diagnoses each year3. One simple test could help transform lives.
We want to open up the conversation about cervical screening - also known as a 'smear test' - providing honest views and relatable advice to help you take control of your cervical health and make an informed decision to book your appointment.
Healthcare sustainability is a growing industry concern, challenging laboratories to do more with less. We aim to provide flexible and high quality services to support you with today’s challenges, and to prepare you for the future.
At Roche Diagnostics we know that innovative diagnostics and therapies are key to transform cancer care. Helping to share knowledge is a central pillar of our work and we achieve this through face to face and online events.
References